/ Not yet recruitingPhase 4 评价醋酸氟氢可的松片治疗失盐型原发性慢性肾上腺皮质功能减退症(Addison 病)的有效性和安全性的多中心、单臂临床研究
[Translation] A multicenter, single-arm clinical study to evaluate the efficacy and safety of fludrocortisone acetate tablets in the treatment of salt-losing primary chronic adrenocortical insufficiency (Addison's disease)
评价醋酸氟氢可的松片治疗 Addison 病患者的有效性和安全性
[Translation] To evaluate the effectiveness and safety of fludrocortisone acetate tablets in the treatment of patients with Addison's disease
评价醋酸氟氢可的松片治疗失盐型先天性肾上腺皮质增生症(CAH)的有效性和安全性的多中心、单臂临床研究
[Translation] A multicenter, single-arm clinical study to evaluate the efficacy and safety of fludrocortisone acetate tablets in the treatment of salt-losing congenital adrenal hyperplasia (CAH)
评价醋酸氟氢可的松片治疗CAH患者的有效性和安全性
[Translation] To evaluate the efficacy and safety of fludrocortisone acetate tablets in the treatment of CAH patients
100 Clinical Results associated with Hefei Future Drug Development Co. Ltd.
0 Patents (Medical) associated with Hefei Future Drug Development Co. Ltd.
100 Deals associated with Hefei Future Drug Development Co. Ltd.
100 Translational Medicine associated with Hefei Future Drug Development Co. Ltd.